Dexmedetomidine protects against ischemia and reperfusion-induced kidney injury in rats by inhibiting the expression of TRPM2 and TRPA1 channels

Document Type : Original Article

Authors

1 Department of Anesthesiology and Reanimation, Faculty of Medicine, Firat University, Elazig, Turkiye

2 Department of Histology and Embryology, Faculty of Medicine, Firat University, Elazig, Turkiye

3 Department of Anesthesiology and Reanimation, Faculty of Medicine, Ankara University, Ankara, Turkiye

4 Department of Histology and Embryology, Faculty of Medicine, Adiyaman University, Adiyaman, Turkiye

10.22038/ijbms.2026.89382.19316

Abstract

Objective(s): Renal ischemia and reperfusion (I/R) injury is a potentially serious issue encountered during various medical and surgical procedures. This condition is clinically significant because of its high incidence and mortality rate. In this study, we aimed to investigate the protective effect of dexmedetomidine (DEX) on oxidative stress-activated TRPM2 and TRPA1 channel expression in rats with a renal I/R model.
Materials and Methods: A total of 35 rats were used in the study. The animals were divided into five groups. The control group received no procedure during the experiment. In the sham group, the abdomen was opened under general anesthesia, the right kidney was removed, and the left renal pedicle was exposed; however, a renal clamp was not applied. The dexmedetomidine group received dexmedetomidine, using the same surgical procedure. In the I/R groups, rats were subjected to left renal ischemia for 30 min followed by 45 min of reperfusion. Dexmedetomidine was not administered to the I/R group, while dexmedetomidine was given to the I/R+DEX group at the beginning of reperfusion. TRPM2 and TRPA1 levels were analysed in serum and kidney tissues at the end of the experiment.
Results: A significant increase in TRPM2 and TRPA1 expression was observed in all samples from the I/R group compared to the non-I/R groups, while a significant decrease in TRPM2 and TRPA1 expression was seen at the I/R+DEX compared to the I/R.
Conclusion: Dexmedetomidine may have renoprotective effects in I/R injury by inhibiting redox-TRP channels.

Keywords

Main Subjects


1. Ren M, Sun LL, Tu YC, Feng L, Yao LJ. Redox TRPs in ıschemia-reperfusion ınjury and their pharmacological value. Front Biosci (Landmark Ed) 2024; 29: 170.
2. Wang X, Lei XG, Wang J. Malondialdehyde regulates glucose- stimulated insulin secretion in murine islets via TCF7L2-dependent Wnt signaling pathway. Mol Cell Endocrinol 2014; 382: 8-16.
3. Maier CM, Sun GH, Kunis DM, Giffard RG, Steinberg GK. Neuroprotection by the N-methyl-D-aspartate receptor antagonist CGP 40116: In vivo and in vitro studies. J Neurochem 1995; 65: 652-659. 
4. Kocoglu H, Karaaslan K, Gonca E, Bozdogan O, Gulcu N. Preconditioning effects of dexmedetomidine on myocardial ischemia/reperfusion injury in rats. Curr Ther Res Clin Exp 2008; 69: 150-158. 
5. Hoffman WE, Kochs E, Werner C, Thomas C, Albrecht RF. Dexmedetomidine improves neurologic outcome from incomplete ischemia in the rat. Reversal by the alpha 2-adrenergic antagonist atipamezole. Anesthesiology 1991; 75: 328-332. 
6. Kocoglu H, Ozturk H, Ozturk H, Yilmaz F, Gulcu N. Effect of dexmedetomidine on ischemia-reperfusion injury in rat kidney: A histopathologic study. Ren Fail 2009; 31: 41-70.
7. Crowther JR. The ELISA guidebook. Methods Mol Biol 2000; 149: 1-413.
8. Ramos-Vara JA. Technical aspects of immunohistochemistry. Vet Pathol 2005; 42: 405-426. 
9. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501. 
10. Caron A, Desrosiers RR, Béliveau R. Kidney ischemia-reperfusion regulates expression and distribution of tubulin subunits, beta-actin and rho GTPases in proximal tubules. Arch Biochem Biophys 2004; 431: 31-46.
11. Shiva N, Sharma N, Kulkarni YA, Mulay SR, Gaikwad AB. Renal ischemia/reperfusion injury: An insight on in vitro and in vivo models. Life Sci 2020; 256: 117860. 
12. Ishii M, Shimizu S, Hara Y, Hagiwara T, Miyazaki A, Mori Y, et al. Intracellular-produced hydroxyl radical mediates H2O2-induced Ca2+ influx and cell death in rat beta-cell line RIN-5F. Cell Calcium 2006; 39: 487-494.
13. Bao N, Tang B. Organ-protective effects and the underlying mechanism of dexmedetomidine. Mediators Inflamm 2020; 2020: 6136105. 
14. Zhao S, Wu W, Lin X, Shen M, Yang Z, Yu S, et al. Protective effects of dexmedetomidine in vital organ injury: Crucial roles of autophagy. Cell Mol Biol Lett 2022; 27: 34.
15. Taoda M, Adachi YU, Uchihashi Y, Watanabe K, Satoh T, Vizi ES. Effect of dexmedetomidine on the release of [3H]-noradrenaline from rat kidney cortex slices: Characterization of alpha2-adrenoceptor. Neurochem Int 2001; 38: 317–322.
16. Curtis FG, Vianna PT, Viero RM, Fiorio PM, Silva LM, Braz JRC, et al. Dexmedetomidine and S+-ketamine in ischemia and reperfusion injury in the rat kidney. Acta Cir Bras 2011; 26: 202-206.
17. Marangoni MA, Hausch A, Vianna PT, Braz JRC, Viero RM, Castiglia YMM. Renal function and histology after acute hemorrhage in rats under dexmedetomidine action. Acta Cir Bras 2007; 22: 291-298.
18. Eraslan E, Tanyeli A, Polat E, Polat E. 8-Br-cADPR, a TRPM2 ion channel antagonist, inhibits renal ischemia-reperfusion injury. J Cell Physiol 2019; 234: 4572-4581.
19. Gao G, Wang W, Tadagavadi RK, Briley NE, Love MI, Miller BA, et al. TRPM2 mediates ischemic kidney injury and oxidant stress through RAC1. J Clin Invest 2014; 124: 4989-5001. 
20. Dembla S, Hasan N, Becker A, Beck A, Philipp SE. Transient receptor potential a1 channels regulate epithelial cell barriers formed by mdck cells. FEBS Lett 2016; 590: 1509-1520. 
21. Wu CK, Wu CL, Su TC, Kou YR, Kor CT, Lee TS, et al. Renal tubular TRPA1 as a risk factor for recovery of renal function from acute tubular necrosis. J Clin Med 2019; 8: 2187.
22. Zhu J, Zhang S, Geng Y, Song Y. Transient receptor potential ankyrin 1 protects against sepsis-induced kidney injury by modulating mitochondrial biogenesis and mitophagy. Am J Transl Res 2018; 10: 4163–4172.
23. Ma S, Zhang Y, He K, Wang P, Wang DH. Knockout of trpa1 exacerbates angiotensin ii-induced kidney injury. Am J Physiol Renal Physiol 2019; 317: F623–F631.
24.  Kun J, Szitter I, Kemeny A, Perkecz A, Kereskai L, Pohoczky K, et al. Upregulation of the transient receptor potential ankyrin 1 ion channel in the inflamed human and mouse colon and its protective roles. PLoS One 2014; 9: 108164.
25. Lowin T, Apitz M, Anders S, Straub RH. Anti-inflammatory effects of n-acylethanolamines in rheumatoid arthritis synovial cells are mediated by trpv1 and trpa1 in a cox-2 dependent manner. Arthritis Res Ther 2015; 17: 321.